EXPERTISE &

CONNECTIONS

Upcoming Events

LIST

FIELD

NOV

20

Cytokine-Based Therapeutics
MicroSummit

Quarter 4: Session 2

Wed, Nov 20, 2024

1:00 PM - 1:00PM (Eastern US)

Engineering the next era of Targeted Immunotherapies

126

NOV

07

Targeted Protein Degradation
MicroSummit

Quarter 3: Session 3

Thu, Nov 7, 2024

1:00 PM - 1:00PM (Eastern US) + CET (NEW)

Harnessing TPD and Induced Proximity for Next-Gen Therapeutics

134

Past Events

2024

Q3

Cell Engager Therapeutics
MicroSummit

Quarter 3: Session 3

Wed, September 18, 2024

10:00 AM - 10:55 AM (Western US)

Unlocking the future of Advanced Therapeutics

121

2024

Q2

mRNA-based Therapeutics
MicroSummit

Quarter 2: Session 3

Tue, June 18, 2024

10:00 AM - 10:55 AM (Western US)

A whirlwind tour of the latest developments in mRNA drug development.

88

2024

Q2

Bispecific Antibody
MicroSummit

Quarter 2: Session 3

Thu, June 20, 2024

10:00 AM - 10:55 AM (Western US)

Accelerating Engineered Antibody Development

93

2024

Q1

Antibody Drug Conjugate
MicroSummit

Quarter 1: Session 3

Wed, March 27, 2024

10:00 AM - 10:55 AM (Western US)

The latest developments in Antibody Drug Conjugate drug development

92

2024

Q1

CAR-T & TCR
MicroSummit

Quarter 1: Session 3

Tue, March 26, 2024

10:00 AM - 10:55 AM (Western US)

A whirlwind tour of the latest developments in CAR-T and TCR-T drug development with an emphasis on Solid Tumors 

89

2023

Q4

Blood Cancer
R&D MicroSummit

Quarter 4: Session 3

Wed, December 20, 2023

10:00 AM - 10:55 AM PDT

A whirlwind tour of the latest developments in Precision Medicine for Hematological drug development

86

2024

Q3

Liquid Biopsy
R&D MicroSummit

Quarter 3: Session 3

Thu, September 28, 2023

10:00 AM - 10:55 AM PDT

Rapid insights on Biomarker strategies, challenges and solutions in Precision oncology and comprehensive platforms in Liquid Biopsy.

88

2023

Q3

Immuno-Oncology
R&D MicroSummit

Quarter 3: Session 3

Tue, September 26, 2023

10:00 AM - 10:55 AM PDT

Novel Immunotherapies and Leading Strategies with rapid insights from Large Pharma and Biotech

96

Contact Us